A study of incidence rates in the US between 1992 and 1999 found that the age-specific incidence rate for HGSC doubles every 10 years up until age 55, where it plateaus at approximately 20 cases per 100,000 women - before dropping dramatically after age 75. Ovarian cancer incidence rates are low in East Asia and<unk> est in Europe, the United States, and Australia/New Zealand. Since 1975, survival rates for ovarian cancer have steadily improved with a mean decrease of 51% by 2006 of risk of death from ovarian cancer for an advanced stage tumour. The increase has mainly been due to successful extended life expectancy of affected patients rather than an improvement in cure rates. A racial disparity exists between black and white women in the US, where black women experience a<unk> er mortality risk from ovarian cancer.
High-grade serous carcinoma
Endometrial stromal sarcoma
Adenomyomatosis
Uterine clear-cell carcinoma
Endometrial stromal tumour
Tubular carcinoma
Uterine serous carcinoma
Papillary serous cystadenocarcinoma